Roberto Luksch

8.9k total citations
189 papers, 4.5k citations indexed

About

Roberto Luksch is a scholar working on Neurology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Roberto Luksch has authored 189 papers receiving a total of 4.5k indexed citations (citations by other indexed papers that have themselves been cited), including 84 papers in Neurology, 60 papers in Pulmonary and Respiratory Medicine and 47 papers in Molecular Biology. Recurrent topics in Roberto Luksch's work include Neuroblastoma Research and Treatments (83 papers), Sarcoma Diagnosis and Treatment (54 papers) and Childhood Cancer Survivors' Quality of Life (29 papers). Roberto Luksch is often cited by papers focused on Neuroblastoma Research and Treatments (83 papers), Sarcoma Diagnosis and Treatment (54 papers) and Childhood Cancer Survivors' Quality of Life (29 papers). Roberto Luksch collaborates with scholars based in Italy, United Kingdom and United States. Roberto Luksch's co-authors include Maura Massimino, Andrea Ferrari, Michela Casanova, Marta Podda, Filippo Spreafico, Monica Terenziani, Alberto Garaventa, Franca Fossati‐Bellani, Paola Collini and Graziella Cefalo and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Roberto Luksch

180 papers receiving 4.4k citations

Peers

Countries citing papers authored by Roberto Luksch

Since Specialization

Citations

This map shows the geographic impact of Roberto Luksch's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roberto Luksch with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roberto Luksch more than expected).

Fields of papers citing papers by Roberto Luksch

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Roberto Luksch. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roberto Luksch. The network helps show where Roberto Luksch may publish in the future.

Co-authorship network of co-authors of Roberto Luksch

This figure shows the co-authorship network connecting the top 25 collaborators of Roberto Luksch. A scholar is included among the top collaborators of Roberto Luksch based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Roberto Luksch. Roberto Luksch is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Dinutuximab Beta Versus Naxitamab in the Treatment of Relapsed/Refractory Neuroblastoma in Patients with Stable Disease, Minor Response or Partial Response and Disease in Bone or Bone Marrow: Systematic Review and Matching-Adjusted Indirect Comparison 2025 ·Cancers ·Holger N. Lode, Przemysław Holko, Aleksandra Wieczorek, Nikolai Siebert, Dominique Valteau‐Couanet, Alberto Garaventa, Adela Cañete, John W. Anderson, Isaac Yaniv, (unknown), Juliet C. Gray, Roberto Luksch, Carla Manzitti, (unknown), (unknown), (unknown), (unknown), Ruth Ladenstein	0
2	Fcγ Receptor Polymorphism in Patients with Relapsed/Refractory High-Risk Neuroblastoma Correlates with Outcomes in the SIOPEN Dinutuximab Beta Long-Term Infusion Trial 2025 ·Clinical Cancer Research ·Holger N. Lode, Nikolai Siebert, Dominique Valteau‐Couanet, Alberto Garaventa, Adela Cañete, John W. Anderson, Isaac Yaniv, (unknown), Juliet C. Gray, Thomas Klingebiel, Hans Loibner, Roberto Luksch, Carla Manzitti, Jean Michon, Cormac Owens, Ulrike Pötschger, (unknown), Evgenia Glogova, Ruth Ladenstein, (unknown)	0
3	ATRT-06. PEDIATRIC INI1-NEGATIVE ATYPICAL TERATOID RHABDOID TUMORS TREATED WITH TAZEMETOSTAT AS MAINTENANCE THERAPY IN THE RELAPSE SETTING: AN ITALIAN SINGLE-CENTRE EXPERIENCE 2024 ·Neuro-Oncology ·Olga Nigro, Veronica Biassoni, Elisabetta Schiavello, Michela Casanova, Luca Bergamaschi, Giovanna Gattuso, Nadia Puma, Giovanna Sironi, Valeria Colombo, Marta Podda, Stefano Chiaravalli, Cristina Meazza, Filippo Spreafico, Andrea Ferrari, Monica Terenziani, Roberto Luksch, Maura Massimino	0
4	Local treatment in initially unresected non‐rhabdomyosarcoma soft‐tissue sarcomas of children and adolescents: A retrospective single‐center experience 2024 ·Pediatric Blood & Cancer ·Andrea Ferrari, Sabina Vennarini, Marco Fiore, Luca Bergamaschi, Stefano Chiaravalli, Carlo Morosi, Chiara Colombo, Emilia Pecori, Nadia Puma, Roberto Luksch, Monica Terenziani, Filippo Spreafico, Cristina Meazza, Marta Podda, Veronica Biassoni, Elisabetta Schiavello, Maura Massimino, Michela Casanova	1
5	Computational intelligence analysis of high-risk neuroblastoma patient health records reveals time to maximum response as one of the most relevant factors for outcome prediction 2023 ·European Journal of Cancer ·Davide Chicco, Riccardo Haupt, Alberto Garaventa, Paolo Uva, Roberto Luksch, Davide Cangelosi	5
6	Cardiotoxicity in children with cancer treated with anthracyclines: A position statement on dexrazoxane 2023 ·Pediatric Blood & Cancer ·Nicoletta Bertorello, Roberto Luksch, Gianni Bisogno, Riccardo Haupt, Paolo Spallarossa, (unknown), Franca Fagioli	9
7	Adolescents and young adults with cancer: Surfing the web to know and manage their disease 2023 ·SHILAP Revista de lepidopterología ·(unknown), (unknown), Francesco Barretta, Giovanna Sironi, Matteo Silva, Roberto Luksch, Monica Terenziani, Michela Casanova, Filippo Spreafico, Cristina Meazza, Marta Podda, Veronica Biassoni, Elisabetta Schiavello, Stefano Chiaravalli, Carlo Alfredo Clerici, Maura Massimino, Andrea Ferrari	1
8	Relapse after nonmetastatic rhabdomyosarcoma: Salvage rates and prognostic variables 2022 ·Pediatric Blood & Cancer ·Luca Bergamaschi, Stefano Chiaravalli, (unknown), Giovanna Sironi, Nadia Puma, Olga Nigro, Giovanna Gattuso, Roberto Luksch, Monica Terenziani, Filippo Spreafico, Cristina Meazza, Marta Podda, Veronica Biassoni, Elisabetta Schiavello, (unknown), Carlo Morosi, Sabina Vennarini, Maura Massimino, Michela Casanova, Andrea Ferrari	4
9	Adult-type non-rhabdomyosarcoma soft tissue sarcomas in pediatric age: Salvage rates and prognostic factors after relapse 2022 ·European Journal of Cancer ·Stefano Chiaravalli, Luca Bergamaschi, (unknown), Giovanna Sironi, Nadia Puma, Olga Nigro, Giovanna Gattuso, Roberto Luksch, Monica Terenziani, Filippo Spreafico, Cristina Meazza, Marta Podda, Veronica Biassoni, Elisabetta Schiavello, Carlo Morosi, Maura Massimino, Michela Casanova, Andrea Ferrari	7
10	Managing Care during the COVID-19 Pandemic: The Point of View and Fears of Pediatric Cancer Patients’ Families 2022 ·Children ·Olga Nigro, Giovanna Sironi, Andrea Ferrari, (unknown), Gabriele Infante, Francesco Barretta, Matteo Silva, Carlo Alfredo Clerici, Stefano Chiaravalli, Elisabetta Schiavello, Veronica Biassoni, Marta Podda, Cristina Meazza, Filippo Spreafico, Michela Casanova, Monica Terenziani, Roberto Luksch, Maura Massimino	0
11	Adolescents with cancer on privacy: Fact-finding survey on the need for confidentiality and space 2021 ·Tumori Journal ·Matteo Silva, Francesco Barretta, Roberto Luksch, Monica Terenziani, Michela Casanova, Filippo Spreafico, Cristina Meazza, Marta Podda, Veronica Biassoni, Elisabetta Schiavello, Stefano Chiaravalli, Nadia Puma, Luca Bergamaschi, Giovanna Gattuso, Giovanna Sironi, (unknown), (unknown), Maura Massimino, Andrea Ferrari	6
12	Extraosseous Ewing sarcoma in children and adolescents: A retrospective series from a referral pediatric oncology center 2021 ·Pediatric Blood & Cancer ·(unknown), Luca Bergamaschi, Nadia Puma, Stefano Chiaravalli, Marta Podda, Michela Casanova, Patrizia Gasparini, Emilia Pecori, (unknown), Olga Nigro, Giovanna Sironi, Giovanna Gattuso, Monica Terenziani, Filippo Spreafico, Cristina Meazza, Veronica Biassoni, Elisabetta Schiavello, Maura Massimino, Roberto Luksch, Andrea Ferrari	8
13	How young patients with cancer perceive the COVID‐19 (coronavirus) epidemic in Milan, Italy: Is there room for other fears? 2020 ·Pediatric Blood & Cancer ·Michela Casanova, (unknown), Matteo Silva, Carlo Patriarca, Laura Veneroni, Carlo Alfredo Clerici, Filippo Spreafico, Roberto Luksch, Monica Terenziani, Cristina Meazza, Marta Podda, Veronica Biassoni, Elisabetta Schiavello, Stefano Chiaravalli, Nadia Puma, Luca Bergamaschi, Giovanna Gattuso, Giovanna Sironi, Maura Massimino, Andrea Ferrari	70
14	Gli adolescenti ammalati di tumore: il “Progetto Giovani” dell’Istituto Nazionale dei Tumori di Milano 2013 ·Recenti Progressi in Medicina ·Andrea Ferrari, Laura Veneroni, Carlo Alfredo Clerici, Filippo Spreafico, Monica Terenziani, Roberto Luksch, Michela Casanova, Cristina Meazza, Daniela Polastri, Lorenza Gandola, Maura Massimino	1
15	Early high-dose treatment: SCT results from the European High Risk Neuroblastoma Study 2011 ·IRIS ·Ruth Ladenstein, Ulrike Pöetschger, Roberto Luksch, Penelope Brock, Victoria Castel, Isaac Yaniv, Vassilios Papadakis, Geneviève Laureys, Josef Mališ, Walentyna Balwierz, Ellen Ruud, Per Kogner, (unknown), (unknown), Maja Beck‐Popovic, (unknown), Miklós Garami, Toby N. Trahair, D Valteau-Couanet	1
16	Comparison of the Prognostic Value of Assessing Tumor Diameter Versus Tumor Volume at Diagnosis or in Response to Initial Chemotherapy in Rhabdomyosarcoma 2010 ·Journal of Clinical Oncology ·Andrea Ferrari, Rosalba Miceli, Cristina Meazza, Michela Casanova, Francesca Favini, Carlo Morosi, Giovanna Trecate, Alfonso Marchianò, Roberto Luksch, Graziella Cefalo, Monica Terenziani, Filippo Spreafico, Daniela Polastri, Marta Podda, Serena Catania, Elisabetta Schiavello, Patrizia Giannatempo, Lorenza Gandola, Maura Massimino, Luigi Mariani	51
17	Mutation-Independent Anaplastic Lymphoma Kinase Overexpression in Poor Prognosis Neuroblastoma Patients 2009 ·Cancer Research ·Lorena Passoni, Luca Longo, Paola Collini, Addolorata Maria Luce Coluccia, Fabio Bozzi, Marta Podda, Andrea Gregorio, Claudio Gambini, Alberto Garaventa, Vito Pistoia, Federica Grosso, Gian Paolo Tonini, Mangeng Cheng, Carlo Gambacorti‐Passerini, Andrea Anichini, Franca Fossati‐Bellani, Massimo Di Nicola, Roberto Luksch	129
18	Diagnostic and prognostic markers in infants with disseminated neuroblastoma: a retrospective analysis from the Italian Cooperative Group for Neuroblastoma. 2009 ·PubMed ·Andrea Di Cataldo, (unknown), Massimo Conte, Stefano Parodi, Bruno De Bernardi, Maria Giuliano, Andrea Pession, Elisabetta Viscardi, Roberto Luksch, Aurora Castellano, (unknown), Riccardo Haupt	10
19	Hyperfractionated Accelerated Radiotherapy in the Milan Strategy for Metastatic Medulloblastoma 2008 ·Journal of Clinical Oncology ·Lorenza Gandola, Maura Massimino, Graziella Cefalo, (unknown), Filippo Spreafico, Emilia Pecori, Daria Riva, Paola Collini, E. Pignoli, Felice Giangaspero, Roberto Luksch, (unknown), Geraldina Poggi, Veronica Biassoni, Andrea Ferrari, Bianca Pollo, Claudio Favre, Iacopo Sardi, Monica Terenziani, Franca Fossati‐Bellani	98
20	Stage 4 neuroblastoma: sequential hemi-body irradiation or high-dose chemotherapy plus autologous haemopoietic stem cell transplantation to consolidate primary treatment 2005 ·British Journal of Cancer ·Roberto Luksch, Marta Podda, Lorenza Gandola, Daniela Polastri, Luigi Piva, Maria Rita Castellani, Paola Collini, Maura Massimino, Graziella Cefalo, Monica Terenziani, Andrea Ferrari, Michela Casanova, Filippo Spreafico, Cristina Meazza, Fabio Bozzi, Alfonso Marchianò, Fernando Ravagnani, Franca Fossati‐Bellani	10

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact